Category Archives: EECP® Therapy Clinical Developments

Chinese Experts Agree on the Benefit of EECP® in Treating Stroke Patients

Last week, an expert panel of physicians in China published an article titled Chinese Consensus Statement on the Evaluation and Intervention of Collateral Circulation for Ischemic Stroke under a Clinical Guideline in CNS Neuroscience & Therapeutics, a peer reviewed scientific journal. The article is based on the group’s review of the most up-to-date evidence-based clinical research and their state-of-the-art, scientific knowledge on ischemic stroke.

In their summary, the authors make the point that “Collateral circulation is becoming more significant in the individual management strategy for ischemic stroke…” and that current data has been recently updated to reflect this. They further note – in the section discussing Indirect Interventions that External Counterpulsation “…increases cardiac output and augments blood flow of vital organs, such as brain, kidney, liver, and myocardium.”

One of the additional recent updates is the inclusion of EECP (Enhanced External Counterpulsation) Therapy in the 2012 Guidelines for the Early Management of Patients With Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association, with a IIb Level of Recommendation (LOR).

Though the use of EECP Therapy is not yet an approved Indication for Use by the U.S. Food and Drug Administration, recently published papers show that recognition of the clinical benefits of EECP Therapy in treating stroke patients by experts in the field are encouraging that one day, in the not too distant future, it will be.

Vasomedical EECP® Therapy App Version 3.0 Now Available!


Vasomedical EECP® Therapy App Version 3.0 Now Available

What’s New in Version 3.0:

– Compatibility with iOS 7

– New and improved user interface

– Improved treatment locator: Find the closest EECP® Therapy centers to your home or office based on your U.S. location!

– Improved Patient questionnaire: Users may answer questions about their symptoms and lifestyle and email the answers to their physician to determine whether or not they are a good candidate for EECP® Therapy

– Improved Angina diary in the Patients section: Users may record angina attacks and email weekly summary to physician for evaluation. A useful tool to assess the effect of EECP® Therapy

-Updated the reimbursement information to year 2013 rates

Vasomedical’s EECP® Therapy App for the iPhone and iPod Touch is designed to provide patients, physicians and EECP® therapists with the information necessary for optimal EECP® therapeutic care. EECP® therapy is a noninvasive, outpatient treatment cleared by the US FDA for patients suffering angina, congestive heart failure (CHF) and other cardiac diseases. In the app, Patients may access information about the therapy as well as view videos showing the therapy systems in operation or former patients sharing their first hand knowledge of how EECP® therapy reduced or eliminated symptoms while improving their quality of life.

Physicians may obtain the latest in patient selection and treatment guidelines to ensure patient safety and satisfaction. Summaries of selected publications in peer reviewed medical journals as well as a complete bibliography for EECP® therapy is at the physicians’ or therapists’ fingertips.

Therapists can also conveniently access treatment information and guidance in the practice and art of treating various patients with the Vasomedical proprietary EECP® systems.

The easy to use locator tab provides patients and physicians with the location of EECP® treatment centers closest to their home or office.

Get The Updated App here:


EECP® Therapy Results in Positive Psychosocial Effects while Reducing Healthcare Costs

We came across a fascinating study showing refractory angina patients undergoing Enhanced External Counterpulsation (EECP®) therapy to experience lower levels of chest pain and higher levels of confidence and self-efficacy. This thesis research by R. Foxwell also finds the patients less afraid of dying – a surprising discovery.

“Not only did (EECP) push me to do it, but also by doing it, it showed me that I don’t need to worry so much about it for the future, so since I’ve come back I’m pushing myself that much more all the time, which is good,” said one of the patients after undergoing the therapy.

We know that EECP stimulates collateral formation—the growth of new blood vessels—that increases blood flow to the heart, having effects similar to exercise.  This thesis confirmed the belief that EECP Therapy reduces the effects of angina, which leads to a more optimistic view of the condition by the patient population, creating a positive cycle of physiological and psychological wellbeing.


The study also finds EECP to have an overall reduction of healthcare expenses. Patients undergoing EECP therapy require less-frequent visits to general practitioners and less medication compared with the period before EECP Therapy.

Such findings motivates everyone here at Vasomedical to push harder to make sure all refractory angina patients learn and have access to EECP® Therapy!

*The study is a dissertation submitted in partial fulfillment of the requirements for the Degree of Doctor of Clinical Psychology in the University of Hull, United Kingdom by Rachel Foxwell, BSc in Psychology, entitled: Psychosocial Outcomes of Enhanced External Counterpulsation Treatment: Illness Perceptions and Psychological Wellbeing”.

Abstract: Improvement of Angina, Quality of Life, and Working Capacity After Enhanced External Counterpulsation

We are thrilled to share this case study from Denmark. The study highlights a woman’s journey towards improvement from angina, a better quality of life and working capacity after receiving Enhanced External Counterpulsation (EECP) Therapy.

A 43-year-old woman was hospitalized 15 times in 6 years because of chest pain. She was diagnosed with reversible ischaemia, a temporary shortage of blood flow to the heart. Her doctor confirmed that she was suffering from Class III angina, based on Canadian Cardiovascular Society (CCS) classification. She experienced chest pain doing simple, everyday living activities, leading to a poor quality of life. With no signs of improvement after going through other recommended treatments, she turned to EECP® Therapy.  After a course of EECP® Therapy, her angina was reduced from Class III to Class I, and she was able to resume normal, everyday activity, allowing her quality of life to improve significantly. Her quality of life remained high for the next three years and she was only admitted to the hospital once due to chest pain.

If you’ve tried other angina treatments with less than satisfying results, ask your doctor about EECP® therapy and hopefully it will work for you too!

Medicinsk Afdeling, Regionshospitalet Herning, Gl. Landevej 61, 7400 Herning.